Besides this, novel therapeutic approaches based on molecular tumor markers were developed like the targeting of epidermal growth factor receptor (EGFR), a highly upregulated receptor in HNSCC associated with poor prognosis. The gene discussed is EGFR; the disease is neoplasm.